Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

about

IL-13 in LPS-Induced Inflammation Causes Bcl-2 Expression to Sustain Hyperplastic Mucous cells.A Small Molecule BH3-mimetic Suppresses Cigarette Smoke-Induced Mucous Expression in Airway Epithelial Cells

P2860

Q47660154-D2FE455F-E298-4985-BCDA-EE3994183D69 Q58740933-4CB57298-8795-4575-A28A-5C2C5D8C8845

P2860

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

Item

http://www.wikidata.org/entity/Q47809313

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

@en

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

@nl

type

Item

label

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

@en

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

@nl

prefLabel

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

@en

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

@nl

P1476

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

@en

P2093

Philip J Kuehl

http://www.w3.org/2001/XMLSchema#string

Yohannes A Mebratu

http://www.w3.org/2001/XMLSchema#string

P2860

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor

Intracellular insulin-like growth factor-1 induces Bcl-2 expression in airway epithelial cells

A genetic variant of p53 restricts the mucous secretory phenotype by regulating SPDEF and Bcl-2 expression.

Roles of apoptosis in airway epithelia.

Type 2 cytokines: mechanisms and therapeutic strategies.

Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies.

Regional particle size dependent deposition of inhaled aerosols in rats and mice.

Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epithelium.

P304

1456-1459.e9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2017.05.038

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P50

Hitendra Chand

Yohannes Tesfaigzi

P577

2017-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28784260

http://www.w3.org/2001/XMLSchema#string

P932

5675799

http://www.w3.org/2001/XMLSchema#string

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

about

P2860

P2860

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932